Edwards Lifesciences had a higher profit and sales in its fourth quarter as demand for its products held strong. The medical-technology company posted a profit of $385.6 million, or 65 cents a share, ...

Edwards Lifesciences beat analysts' estimate for fourth-quarter profit on Tuesday, helped by strong demand for its artificial heart valves and other medical devices.

Pre-earnings options volume in Edwards Lifesciences (EW) is normal with calls leading puts 9:2. Implied volatility suggests the market is ...

EST Edwards Lifesciences (EW) sees Q EPS , consensus Maximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' ...

Edwards Lifesciences Corp (NYSE:EW) reported strong financial results for the fourth quarter of 2024, surpassing analysts' expectations with an adjusted earnings per share (EPS) of $0.59 against a ...

Edwards Lifesciences (NYSE: EW) shares got a boost after hours today on fourth-quarter results that came in ahead of the consensus forecast.

For the quarter ended December 2024, Edwards Lifesciences (EW) reported revenue of $1.39 billion, down 9.7% over the same period last year. EPS came in at $0.59, compared to $0.64 in the year-ago ...

Many, or all, of the products featured on this page are from our advertising partners who compensate us when you take certain actions on our website or click to take an action on their website ...

Company has N G Jain & Co. as its auditors. As on 31-03-2024, the company has a total of 2.38 Crore shares outstanding.Avon Lifesciences Share Price Today is Rs. 2.86. On previous day, the Avon ...

Supriya Lifescience Ltd., incorporated in the year 2008, is a Large Cap company (having a market cap of Rs 6,226.15 Crore) operating in Pharmaceuticals sector. Supriya Lifescience Ltd. key ...